Status:
COMPLETED
COVID-19 : Pulmonary Ultrasound in Primary Care
Lead Sponsor:
Geprovas
Conditions:
Covid19
Pulmonary Infection
Eligibility:
All Genders
18+ years
Brief Summary
COVID-19 infection are characterized by fever and signs of acute respiratory infection. A worsening of respiratory symptoms that can lead to respiratory failure. The decompensation can then be brutal ...
Eligibility Criteria
Inclusion
- Patients over 18 years of age with :
- a clinical symptomatology suggesting an acute respiratory infection linked to COVID-19 defined by the following two categories of symptoms:
- Sudden fever (or a feeling of fever)
- Respiratory signs (cough, dyspnea, chest tightness) Or
- an acute respiratory infection confirmed to COVID-19 by the result of RT-PCR screening tests.
- And presenting, at the time of inclusion between the 5th and 10th day of infection, one of the respiratory signs of severity felt:
- Dyspnea, shortness of breath or difficulty in breathing
- Chest pain or tightness
Exclusion
- The presence of a severe form during the initial consultation. A severe form is defined by the presence of the following signs:
- Polypnea\> 22 / min
- systolic BP \<90 mmHg
- Sp02 \<90%
- Altered consciousness, confusion, drowsiness
- Dehydration
- Alteration of the general condition in the elderly
- The presence of acute respiratory signs clearly having a cause other than a COVID-19 infection.
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT05226403
Start Date
July 1 2020
End Date
December 31 2021
Last Update
February 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GEPROVAS
Strasbourg, France, 67000